Immunotherapy: Open Access
Open Access

High Impact List of Articles

• Aviscumine (ME-503)-Skin Reaction as significant Factor for its Efficacy Expanded Evaluation of the Results from the Phase II Trial NCT00658437 in Patients with Unresectable stage IV Metastatic Melanoma
  Uwe Trefzer, Ralf Gutzmer, Tabea Wilhelm, Florian Schenck, Katharina C. Kähler, Volkmar Jacobi, Klaus Witthohn, Hans Lentzen* and Peter Mohr

  Research Article: Immunotherapy: Open Access

• The Kynurenine/Tryptophan Ratio and Glioblastoma Patients Treated with Hsppc-96 Vaccine
  Alicia Lenzen, Lijie Zhai, Kristen L Lauing, Galina Gritsina, Erik Ladomersky, Matthew Genet, C David James, Orin Bloch, and Derek A Wainwright

  Commentary: Immunotherapy: Open Access

• Better Together: Immunotherapy as Future Combination Strategy for Breast Cancer
  Elisa Zanardi and Serena Di Cosimo

  Commentary: Immunotherapy: Open Access

• Evaluation of Skin Reactivity during (Immuno-) Therapy. Validation of Methods for Estimation of Changes in Skin Reactivity and Correlation to Shock Organ Sensitivity
  Sten Dreborg, Antonio Basomba, Thorvald Löfkvist, Margareta Holgersson and Christian Möller

  Research Article: Immunotherapy: Open Access

• Antibody Therapeutics in Oncology
  Erik D Wold, Vaughn V Smider and Brunhilde H Felding

  Review Article: Immunotherapy: Open Access

Relevant Topics in Immunology & Microbiology